What is NDC 49281-860?

49281-860 is the product NDC for Ipol, Poliovirus type 1 antigen (Formaldehyde inactivated) 40 [D'ag'U]/.5mL + 2 more ingredients injection, suspension, listed with the FDA by Sanofi Vaccines US Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Ipol (POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)).

What is the active ingredient?

Poliovirus type 1 antigen (Formaldehyde inactivated), Poliovirus type 2 antigen (Formaldehyde inactivated), Poliovirus type 3 antigen (Formaldehyde inactivated).

Sanofi Vaccines US Inc., NDC labeler code 49281. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ipol?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ipol NDC 49281-860 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)49281-860Labeler and product segments. Claims need a package NDC.

Product NDC at billing width49281-0860Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
49281-860-10	4928108601049281086010	1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-860-10) / 5 mL in 1 VIAL, MULTI-DOSE (49281-860-78)Marketed from Dec 21, 1990

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ipol
Generic name (nonproprietary): poliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen (formaldehyde inactivated)
Active ingredients: Poliovirus type 1 antigen (Formaldehyde inactivated) — 40 [D'ag'U]/.5mLPoliovirus type 2 antigen (Formaldehyde inactivated) — 8 [D'ag'U]/.5mLPoliovirus type 3 antigen (Formaldehyde inactivated) — 32 [D'ag'U]/.5mL
Dosage form: Injection, Suspension
Route: Intramuscular
Labeler: Sanofi Vaccines US Inc.NDC labeler code 49281
Product type: Vaccine
Marketing category: BLA — Biologics License ApplicationApplication BLA 103930
Marketing start: Dec 21, 1990
Listing expires: Dec 31, 2027
Other FDA classes: Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Poliovirus Vaccines (Chemical structure)Poliovirus Vaccines (Chemical structure)Poliovirus Vaccines (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)
Identifiers: Product ID 49281-860_d10c6d10-6bd1-4551-8176-69d08419b958SPL ID d10c6d10-6bd1-4551-8176-69d08419b958
Pharmacologic class: Inactivated Poliovirus Vaccine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N449281086010 followed by a unit qualifier and the quantity

Package 49281-0860-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 49281-860

What is NDC 49281-860?: 49281-860 is the product NDC for Ipol, Poliovirus type 1 antigen (Formaldehyde inactivated) 40 [D'ag'U]/.5mL + 2 more ingredients injection, suspension, listed with the FDA by Sanofi Vaccines US Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ipol (POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)).
What is the active ingredient?: Poliovirus type 1 antigen (Formaldehyde inactivated), Poliovirus type 2 antigen (Formaldehyde inactivated), Poliovirus type 3 antigen (Formaldehyde inactivated).
Who is the labeler?: Sanofi Vaccines US Inc., NDC labeler code 49281. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ipol?: 1 other product NDC are listed under this name. See all Ipol NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ipol NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ipolpoliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen (formaldehyde inactivated)	Poliovirus type 1 antigen (Formaldehyde inactivated) 40 [D'ag'U]/.5mL + 2 more ingredients	Injection, SuspensionIntramuscular	A-S Medication Solutions	50090-1693	50090-1693-09

Other NDCs under BLA 103930

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 103930
Product	Strength	Form · route	Labeler	Product NDC
Ipolpoliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen (formaldehyde inactivated)	Poliovirus type 1 antigen (Formaldehyde inactivated) 40 [D'ag'U]/.5mL + 2 more ingredients	Injection, SuspensionIntramuscular	A-S Medication Solutions	50090-1693